FDA Emergency Use Authorized
This high-performance rapid test enables immediate treatment or isolation measures to minimize transmission.
Simple to Conduct with a Low Potential for Erroneous Results
The INDICAID® COVID-19 Rapid Antigen Test (CE-IVD) is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples.
In a prospective US clinical study, INDICAIDTM accurately identified 84% of those who were positive (PPA) and 97% of those who were negative (NPA) for SARS-CoV-2.
Intended for both laboratory and point-of-care settings, the Indicaid rapid test is now newly authorized for over the counter or non-prescription self testing at home by the US Food and Drug Administraion (FDA) under an Emergency Use EUA.
Contact Vennwest WeAir Sales For Your Client ID
Rapid Test Features
Quick Working: Intuitive visual results in 20 minutes
High Sensitivity: Clinically validated with overall specificity and sensitivity at 99% and 89.1% respectively
Affordable: Diagnosis at a fraction of the price
Easy-To-Use: No training, special equipment or facilities needed
Batch Testing: Easily collect and test multiple samples
Online App: Keep track and manage your test results (coming soon)
Shelf Life: 12 Months
INDICAID ANTIGEN INFO PACKAGE
EUROPEAN EUA DOCUMENTATION
RAPID TEST GUIDE
Pricing Varies w/ Quantity and Current Market Conditions
Contact Us For Quotes of 500,000 Quantity & Over
Boxes per case: 18
Tests per case: 450
ORDER & DELIVERY
Online Portal For Ordering
Products are delivered within 3-5 days